Prospective Cohort to Explore the Impact of COVID-19 Infection on Assisted Reproductive Assisted Conception Outcomes in Women with Assisted Reproductive Assisted Conception

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400080230

Enrollment

Unknown

Registered

2024-01-24

Start date

2023-02-08

Completion date

Unknown

Last updated

2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Infection

Interventions

Experimental group 1: New crown positive patients (nucleic acid positive or antigen positive):None

Experimental group 2: suspected new crown infection (no nucleic acid or antigen detected, but clinical symptoms):None

Control group: no history of positive nucleic acid or antigen and no signs of new crown infection.:None

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All patients with transplant cycles during the study period (2022.12.01-2022.12.31);

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy rate;Live birth rate;Abortion rate;Peripheral blood immune cell test;Five thyroid function tests;	—

Secondary

Measure	Time frame
Eukaryotic embryo rate;Embryo implantation rate;	—

Countries

China

Contacts

Public ContactGong Fei

CITIC Xiangya Specialist Hospital for Reproduction and Genetics

linggf@hotmail.com+86 139 0748 5296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026